🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

New AI-powered skin cancer detection technology could enable at-home assessment

Published 12/07/2024, 01:30 pm
Updated 12/07/2024, 02:00 pm
© Reuters.  New AI-powered skin cancer detection technology could enable at-home assessment
PAIYY
-

A new AI-driven skin cancer detection technology in development by Australian company AI Medi Scan may soon allow Australians to check themselves for skin cancer at home.

The Cancer Council estimates two in three Australians will be diagnosed with some sort of skin cancer during their lifetime and about 2,000 Australian die from skin cancer every year, according to Sun Smart.

Some 95% of melanomas, the most dangerous form of skin cancer, can be resolved with simple surgery if caught early enough.

AI Medi Scan’s technology is designed to use fluorescence imaging and artificial intelligence (AI) to analyse skin abnormalities across different light spectrums.

The company believes its diagnostic tech will improve the accuracy of non-invasive diagnosis and reduce the pressure on dermatologists, who are in short supply in Australia with only about 600 specialists practising, about two dermatologists for every 100,000 Australians.

“In terms of having access to early diagnosis, which we know particularly for melanoma is just vital, having access to good quality, consistent, accessible and affordable health care, I think that’s a big issue for Australians,” Australasian College of Dermatologists president Dr Clare Tait said in an interview with Dermatology Republic.

Risk profiling program

AI Medi Scan says its technology will enable users to conduct skin checks at home, alleviating the strain on healthcare providers and offering timely access to potentially lifesaving diagnoses.

Importantly, there is no plans for the technology to replace skin checks by trained doctors, but ideally it will reduce wait times for appointments and augment diagnosis efforts.

"Our product will not only improve diagnostic accuracy but also reduce the likelihood of false negatives, a crucial factor in skin cancer detection,” Founder Haoyuan Ma said.

The company plans to collaborate with government and industry to develop a national risk profiling program with the aim of supporting vulnerable populations and integrating AI Medi Scan’s technologies with existing healthcare services.

The Australasian College of Dermatologists acknowledges that accessing dermatology services can be challenging.

“There is a substantial workforce shortage which is particularly acute in regional, rural and remote Australia with only 6% living and practising in these areas,” the College’s website reads.

“The shortage is not due to a lack of doctors interested in becoming dermatologists but rather the limited number of training and supervisor positions in the public system.”

This years’ Federal Budget included a $25 million commitment to prevention and early detection of skin cancer and melanoma, with $10.3 million allocated to develop a roadmap for a targeted skin cancer screening program.

Read more on Proactive Investors AU

Disclaimer

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.